# Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

> **NCT01170091** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 651 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01170091
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 651 (ACTUAL)
- **Last updated:** 2014-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01170091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01170091, "Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01170091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*